Search
Close this search box.

Fort Walton Medical Center offering antibody infusions for high-risk COVID patients

Fort Walton Beach Medical Center is now offering bamlanivimab antibody infusions to non-hospitalized patients who have tested positive for COVID-19 and have other high-risk factors.  The first patient received the treatment on December […]

Fort Walton Beach Medical Center nurse administering the antibody infusion to a patient.

Fort Walton Beach Medical Center is now offering bamlanivimab antibody infusions to non-hospitalized patients who have tested positive for COVID-19 and have other high-risk factors. 

The first patient received the treatment on December 22 making Fort Walton Beach Medical Center the only hospital in the tri-county area to offer this antibody infusion.

The FDA granted Emergency Use Authorization of bamlanivimab for the treatment of COVID-19 patients experiencing mild to moderate symptoms who are high risk to develop severe COVID-19.  Fort Walton Beach Medical Center will provide the outpatient IV treatment for adults and adolescents age 12 and older.

High-risk conditions that may be eligible for this treatment include:

  • Obesity
  • 65+ years of age
  • Chronic kidney disease
  • COPD
  • Diabetes
  • Immunosuppressive disease
  • Heart disease
  • For children over the age of 12, sickle cell disease, neurodevelopmental disorders, and asthma are also among several additional considerations for eligibility.

“We’re committed to providing our patients, caregivers, and the communities we serve with the latest treatments in the fight against COVID-19 and are excited to bring this option to the tri-county area,” said Dr. Bob Kiskaddon, Chief Medical Officer for Fort Walton Beach Medical Center. “We will support all of our local hospitals in working closely with physicians and other providers across the communities we serve to provide treatment to patients who may benefit, per FDA guidelines.”

The medication supply is limited and based on availability. Patients will need a physician referral and meet FDA criteria prior to scheduling, according to the hospital.  The treatment is a one-time intravenous infusion over the course of one hour followed by an hour of monitoring.

bamlanivimab is not authorized for use for patients who:

  • Are hospitalized due to COVID-19
  • Require oxygen therapy due to COVID-19
  • Require supplemental oxygen for other conditions and require an increase in their oxygen requirement.

For more information on monoclonal antibody treatment for COVID-19, visit the Coronavirus Hub at www.fwbmc.com/covid-19.

PROMOTION

Join the conversation...

Continue reading 👇

Community Comments

“Great to know my nephew Ryan "Jume" Jumonville is supporting our nations defenders.”
Respond
“Hi Get The Coast — Thank you for this article. Do you intend to publish the candidates’ answers to the full slate of questions? If so - thank you! If...”
Respond
Scott Schaeffler commented on WordroW: October 20, 2026
“0:40, 4 attempts”
Respond
“My family and I crossed the Atlantic in 1961 on the United States. I wish that they could have saved her! I think the coin should be made available as...”
Respond
“From the Public Comment Dock: Has My Branch Pile Been Snubbed? Dearest readers, Today’s question: if the debris truck passes one’s house without collecting everything, must one immediately demand an...”
Respond
Denise commented on WordroW: October 16, 2026
“fun game”
Respond
“Where can we find your list of all 10 questions?”
Respond
“They've done a great job. Let's consider burying lines from here on out”
Respond
Anne Porter commented on WordroW: October 14, 2026
“Having been without TV since Isiasis, give us an update on Spectrim’s progress restoring cable, please,”
Respond
“It is Wednesday morning Oct.14 and we have a downed electric pole in our front yard in incorporated Okaloosa county. So no thanks from us. We reported it when it...”
Respond

GET OUR FREE LOCAL NEWSLETTER

Get the weekday email that actually makes reading local news enjoyable again.